Protective effects of active hexose correlated compound (AHCC) on the onset of diabetes induced by streptozotocin in the rat

Biomedical Research

Volumn 20, Issue 3, 1999, Pages 145-152

  Wakame, Koji ^a,b  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

^b Amino Up Chemical Co   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVE HEXOSE CORRELATED COMPOUND; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; DRINKING WATER; GLUCOSE; HEXOSE; INSULIN; LIPID PEROXIDE; STREPTOZOCIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; GLUCOSE BLOOD LEVEL; IMMUNOREACTIVITY; INSULIN BLOOD LEVEL; LANGERHANS CELL; LIPID BLOOD LEVEL; MALE; NONHUMAN; PANCREAS ISLET BETA CELL; RAT; STREPTOZOCIN DIABETES; WEIGHT GAIN;

ANIMALIA;

EID: 0032843046     PISSN: 03886107     EISSN: None     Source Type: Journal    
DOI: 10.2220/biomedres.20.145     Document Type: Article

References (28)

1. Baynes J.W. (1991) Role of oxidative stress in development of complications in diabetes. Diabetes 40, 405-412.
2. Craft N.E. and Failla M.L. (1983) Zinc, iron, and copper absorption in the streptozotocin-diabetic rat. Am. J. Physiol. 244, E122-E128.
3. Failla M.L. and Kiser R.A. (1983) Altered tissue content and cytosol distribution of trace metals in experimental diabetes, J. Nutr. 111, 1900-1909.
4. Genuth S.M. (1973) Plasma insulin and glucose profiles in normal, obese, and diabetic persons. Ann. Intern. Med. 79, 812-822.
5. Henry R.J., Chiamori N., Golub D.D. and Berkman S. (1960) Revised spectrophotometric methods for the determination of glutamic-oxalacetic transaminase, glutamicpyruvic transaminase, and lactic acid dehydrogenase. Am. J. Clin. Path. 34, 381-398.
6. Herr R.R., Eble T.E., Bergy M.F. and Jahnke H.K. Isolation and characterization of streotpzotocin (1960) Antibiot. Annual 1959-1960. 236-240.
7. Junod A., Lambert A.E., Stauffacher W. and Renold A.E. (1969) Diabetogenic action of streptozotocin: relationship of dose to metabolic response. J. Clin. Invest. 48, 2129-2139.
8. Kannel W.B. and Mcgee, Dl (1979) Diabetes and cardiovascular disease. JAMA 241, 2035-2038.
9. Kawada J. (1992) New hypothesis for the mechanisms of streptozotocin and alloxan inducing diabetes mellitus. Yakugaku Zasshi 112, 773-791 (in Japanese).
10. Kitade H., Matsui Y., Takai S., Imamura A., Kawaguchi Y., Kamiyama Y., Sun B. and Kosuna K. (1998) XXXIII-rd Congress of the European Society for Surgical Research, p.74 (Ab).
11. Kosuna K. (1999) Recent progress of research on AHCC (Active Hexose Correlated Compound), New Food Industry 41, 17-23 (in Japanese).
12. Luo W.Q., Kanno T., Winarto A., Iwanaga T., Jun L., Futai Y., Yanahara C. and Yanahara N. (1998) An experimental analysis of therapeutic effects of a Chinese herbal prescription in streptozocin-treated rats. Biomed. Res. 19, 127-133.
13. Mukoda T., Sun B. and Kosuna K. (1998) Active Hexose Correlated Compound (AHCC) protects against cytosine arabinoside induced alopecia in the newborn rat animal model. Jpn. J. Cancer Res. 89, p.2405 (Ab).
14. Matsushita K., Kuramitsu Y., Ohiro Y., Obara M., Kobayashi M., Li Y.Q. and Hosokawa M. (1998) Combination therapy of Active Hexose Correlated Compound plus UFT significantly reduces the metastasis of rat mammary adenocarcinoma. Anti-Cancer Drugs 9, 343-350.
15. O'Brien B.A., Harmon B.V., Cameron O.P. and Allan D. J. (1997) Apoptosis is the mode of β-cell death responsible for the development of IDDM in the nonobese diabetic (NOD) mouse. Diabetes 46, 750-757.
16. Okamoto H. (1985) Molecular basis of experimental diabetes: degeneration, oncogenesis and regeneration of pancreatic β-cells of islets of Langerhans. Bioessays 2, 15-21.
17. Prichard K.A., Patel ST., Karpen C.W., Newman H.A.I, and Panganamala R.V. (1986) Triglyceride-lowering effect of dietary vitamin E in streptozotocin-induced diabetic rats. Diabetes 35, 278-281.
18. Rakieten N., Rakieten M.L. and Nadkarmi M.V. (1963) Studies on the diabetogenic action of streptozotocin (NSC-37917). Cancer Chemother. Rep. 29, 91-98.
19. Rerup C.C. (1970) Drugs producing diabetes through damage of the inslin secreting cells. Pharmacol. Rev. 22, 485-519.
20. Rhee S.J., Choe W.K. and Ha T.Y. (1995) The effect of vitamin E on the antioxidative defense mechanism in streptozotocin-induced diabetic rats. J. Jpn. Soc. Nutr. Food Sci. 48, 451-457 (in Japanese).
21. Saudek C.D. and Eder H.A. (1979) Lipid metabolism in diabetes mellitus. Am. J. Med. 66, 843-852.
22. Sun B., Friedman M. and Kosuna K. (1998) Effect of AHCC (Active Hexose Correlated Compound) in both the prevention and treatment of carcinomas. Critical Appraisal of Unconventional/Alternative Interventions for Carcinoma of the Prostate. (Ab).
23. Sun B., Wakame K., Mukoda T., Toyoshima A., Kanazawa T. and Kosuna K. (1997) Protective effects of AHCC on carbon tetrachloride induced liver injury in mice. Natural Med. 51, 310-315 (in Japanese).
24. Tomoda M., Gonda R., Kasahara Y. and Hikino H. (1986) Glycan structure of ganoderans B and C, hypoglycemic glycans of Ganoderma lucidum fruit bodies. Phytochemistry 25, 2817-2820.
25. Urano S., Hoshi-Hashizume M., Tochigi N., Matsuo M., Shiraki M. and Ito H. (1991) Vitamin E and the susceptibility of erythrocytes and reconstituted liposomes to oxidative stress in aged diabetes. Lipids 26, 58-61.
26. Wagner H. (ed) (1999) Immunomodulatory Agents from Plants. Birkhauser Verlag, Basel, Boaton, Berlin.
27. Yagi K. (1976) A simple fluorometric assay for lipoperoxide in blood plasm. Biochem. Med. 15, 212-216.
28. Yagita A., Maruyama S., Fujitsuka M., and Ohshima K. (1998) Novel immunotherapy using a human natural (Hn) IL-12 inducer. Jpn. J. Cancer. Res. 89, p.2422 (Ab).